Trade BIVI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
BioVie Inc. Class A (BIVI) is trading at US$2.23, up 1.83% today as of Aug 28, 12:09 EDT. The company has a market capitalisation of US$16.48M. Over the past 52 weeks, BIVI has traded between US$0.82 and US$3.79. On Syfe you can trade BIVI with $0 commission and add it to your watchlist.
| Previous close | US$2.19 |
|---|---|
| Market cap | US$16.48M |
| 52-week range | US$0.82 – US$3.79 |
| Volume | 671.93K |
| Exchange | US |
Add to Watchlist
Set Price Alert
BioVie Inc. Class A
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders, and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
Year: 2014
BioVie Files $300 Million Mixed Shelf
Jun 18, 9:46 PM · MT Newswires
BioVie Inc. Class A (BIVI) stock is trading at US$2.23, +1.83% from the previous close of US$2.19.
The market cap for BioVie Inc. Class A (BIVI) stock is approximately US$16.48M.
The 52-week high for BioVie Inc. Class A (BIVI) stock is US$3.79.
The 52-week low for BioVie Inc. Class A (BIVI) stock is US$0.82.
BioVie Inc. Class A (BIVI) does not currently pay a dividend.
Stay on top of BIVI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
